[Orphan diseases: evaluations of new treatments]

J F Bergmann1, V Delcey, K Champion

  • 1Service de Médecine Interne A, Hôpital Lariboisière, 2, rue Ambroise Paré, 75475 Paris 10, France. jf.bergmann@lrb.aphp.fr

La Revue De Medecine Interne
|January 30, 2008
PubMed

Insights

New orphan disease treatments require rigorous evaluation using therapeutic trial methods like randomized controlled trials. Ensuring clinical and statistical significance is crucial for valid efficiency assessments, even with relaxed rules.

Area of Science:

  • Medical Research
  • Clinical Trials
  • Rare Diseases

Background:

  • Orphan diseases affect a small patient population, posing unique challenges for clinical research.
  • Traditional therapeutic trial methodologies are essential for evaluating new treatments.

Purpose of the Study:

  • To outline the methodological standards for assessing new orphan disease treatments.
  • To emphasize the importance of rigorous evaluation for therapeutic efficiency.

Main Methods:

  • Adherence to established therapeutic trial rules, including randomized controlled trials.
  • Defining a single primary endpoint for clear outcome measurement.
  • Ensuring statistically significant and clinically relevant efficacy.

Main Results:

  • Methodological rules for therapeutic trials are critical for orphan disease treatment evaluation.
  • While some rules may be adapted, the standard of therapeutic efficiency must be maintained.

Conclusions:

  • Rigorous evaluation of orphan disease treatments is paramount.
  • Therapeutic trial standards ensure the reliability and validity of treatment efficacy data.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...